[EN] NOVEL AROMATIC AMINES AND AMIDES ACTING ON THE MELANOCORTIN RECEPTORS<br/>[FR] NOUVEAUX AMINES ET AMIDES AROMATIQUES AGISSANT SUR LES RECEPTEURS DE LA MELANOCORTINE
申请人:MELACURE THERAPEUTICS AB
公开号:WO2001055107A2
公开(公告)日:2001-08-02
The present invention relates to novel aromatic amines and amides of general formula (I) and to the use of these amines and amides for the treatment of obesity, anorexia, inflammation, mental disorders and other diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones.
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery
(hTLR4) modulation virtual high throughput screening by a peta-flops-scale supercomputer has been performed. Based on the in silico studies, a series of 12 compounds related to tryptamine was rationallydesigned to retain suitable molecular geometry for interaction with the hTLR4 binding site as well as to satisfy general principles of drug-likeness. The proposed compounds were synthesized, and tested